Income Taxes (Tables)
|
12 Months Ended |
Dec. 31, 2023 |
| Income Taxes |
|
| Schedule Components of loss before income taxes and the provision for income taxes |
The components of loss before income taxes and the income tax (expense) benefit for the years ended December 31, 2023, 2022, and 2021, by jurisdiction, are as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2023 | | 2022 | | 2021 | | | U.S. | | Foreign | | Total | | U.S. | | Foreign | | Total | | U.S. | | Foreign | | Total | Loss before income taxes | | $ | (1,211,796) | | $ | (164,401) | | $ | (1,376,197) | | $ | (697,342) | | $ | (25,827) | | $ | (723,169) | | $ | (466,825) | | $ | (9,337) | | $ | (476,162) | Income tax (expense) benefit | | | 29 | | | 7,335 | | | 7,364 | | | 868 | | | (1,707) | | | (839) | | | 16,540 | | | (343) | | | 16,197 | Net loss | | $ | (1,211,767) | | $ | (157,066) | | $ | (1,368,833) | | $ | (696,474) | | $ | (27,534) | | $ | (724,008) | | $ | (450,285) | | $ | (9,680) | | $ | (459,965) |
|
| Schedule of Significant Components of Deferred Income Tax Expense (Benefit) |
The significant components of current and deferred income tax expense (benefit) for the years ended December 31, 2023, 2022, and 2021, by jurisdiction, are as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | 2023 | | 2022 | | 2021 | | | U.S. | | Foreign | | Total | | U.S. | | Foreign | | Total | | U.S. | | Foreign | | Total | Current income tax (benefit) expense | | $ | — | | $ | 1,170 | | $ | 1,170 | | $ | — | | $ | 668 | | $ | 668 | | $ | — | | $ | — | | $ | — | Deferred tax (benefit) expense | | | (100,754) | | | (2,618) | | | (103,372) | | | (42,705) | | | 6,968 | | | (35,737) | | | (51,999) | | | 1,064 | | | (50,935) | Net operating loss carryforward generated | | | (146,174) | | | (17,653) | | | (163,827) | | | (92,030) | | | 4,332 | | | (87,698) | | | (105,498) | | | (2,038) | | | (107,536) | Valuation allowance increase (decrease) | | | 246,899 | | | 11,766 | | | 258,665 | | | 133,867 | | | (10,261) | | | 123,606 | | | 140,957 | | | 1,317 | | | 142,274 | Expense (benefit) for income taxes | | $ | (29) | | | (7,335) | | $ | (7,364) | | $ | (868) | | $ | 1,707 | | $ | 839 | | $ | (16,540) | | $ | 343 | | $ | (16,197) |
|
| Schedule of Effective Income Tax Rate Reconciliation |
| | | | | | | | | | 2023 | | 2022 | | 2021 | | U.S. Federal statutory tax rate | | (21.0) | % | (21.0) | % | (21.0) | % | Deferred state taxes | | 0.0 | % | 0.0 | % | (0.6) | % | Common stock warrant liability | | 0.0 | % | 0.0 | % | (6.0) | % | Section 162M Disallowance | | 0.7 | % | 1.9 | % | 1.1 | % | Equity Compensation | | 0.4 | % | (0.7) | % | (4.3) | % | Provision to return and deferred tax asset adjustments | | (2.1) | % | 4.6 | % | (1.3) | % | Change in U.S. Federal/Foreign statutory tax rate | | (0.1) | % | 0.0 | % | 0.3 | % | Other, net | | 0.6 | % | 0.6 | % | (1.5) | % | Impairment of goodwill | | 3.3 | % | 0.0 | % | 0.0 | % | Change in valuation allowance | | 17.7 | % | 14.8 | % | 29.9 | % | | | (0.5) | % | 0.1 | % | (3.4) | % |
|
| Schedule of Deferred Tax Assets and Liabilities |
The Company has recorded a net deferred tax liability in other non-current liabilities, at December 31, 2023 and 2022 of approximately $3.2 million and $11.5 million, respectively. Significant components of the Company’s deferred tax assets and liabilities as of December 31, 2023 and 2022 are as follows (in thousands): | | | | | | | | | | | | | | | | | | | | | U.S. | | Foreign | | Total | | | 2023 | | 2022 | | 2023 | | 2022 | | 2023 | | 2022 | Deferred revenue | | | 39,241 | | | 33,172 | | | 142 | | | 137 | | | 39,383 | | | 33,309 | Interest expense | | | 28,126 | | | 31,368 | | | — | | | — | | | 28,126 | | | 31,368 | Other reserves and accruals | | | 57,265 | | | 26,591 | | | 337 | | | 287 | | | 57,602 | | | 26,878 | Tax credit carryforwards | | | 20,794 | | | 14,949 | | | — | | | — | | | 20,794 | | | 14,949 | Amortization of stock-based compensation | | | 44,023 | | | 30,217 | | | — | | | — | | | 44,023 | | | 30,217 | Non-compensatory warrants | | | 2,950 | | | 6,268 | | | — | | | — | | | 2,950 | | | 6,268 | Capitalized research & development expenditures | | | 82,374 | | | 60,588 | | | — | | | — | | | 82,374 | | | 60,588 | Right of use liability (operating leases) | | | 41,960 | | | 32,616 | | | — | | | 259 | | | 41,960 | | | 32,875 | Capital loss carryforwards | | | 1,763 | | | — | | | — | | | — | | | 1,763 | | | — | Net operating loss carryforwards | | | 443,964 | | | 297,790 | | | 25,373 | | | 7,720 | | | 469,337 | | | 305,510 | Total deferred tax asset | | | 762,460 | | | 533,559 | | | 25,852 | | | 8,403 | | | 788,312 | | | 541,962 | Valuation allowance | | | (676,190) | | | (429,291) | | | (19,949) | | | (8,183) | | | (696,139) | | | (437,474) | Net deferred tax assets | | $ | 86,270 | | $ | 104,268 | | $ | 5,903 | | $ | 220 | | $ | 92,173 | | $ | 104,488 | Intangible assets | | | (27,749) | | | (29,731) | | | (9,088) | | | (9,938) | | | (36,837) | | | (39,669) | Convertible debt | | | — | | | (26,989) | | | — | | | — | | | — | | | (26,989) | Right of use asset (operating leases) | | | (50,632) | | | (40,194) | | | — | | | (260) | | | (50,632) | | | (40,454) | Property, plant and equipment and right of use assets | | | (7,889) | | | (7,383) | | | — | | | (1,500) | | | (7,889) | | | (8,883) | Deferred tax liability | | $ | (86,270) | | $ | (104,297) | | $ | (9,088) | | $ | (11,699) | | $ | (95,358) | | $ | (115,996) | Net | | $ | — | | $ | (29) | | $ | (3,185) | | $ | (11,479) | | $ | (3,185) | | $ | (11,508) |
|
| Schedule of Valuation Allowance |
A reconciliation of the current year change in valuation allowance is as follows (in thousands): | | | | | | | | | | | | U.S. | | Foreign | | Total | Increase in valuation allowance for current year increase in net operating losses | | $ | 177,299 | | | 11,496 | | $ | 188,795 | Increase in valuation allowance for current year net increase in deferred tax assets other than net operating losses | | | 69,600 | | | — | | | 69,600 | Increase in valuation allowance due to change in tax rates | | | — | | | 270 | | | 270 | Net increase in valuation allowance | | $ | 246,899 | | $ | 11,766 | | $ | 258,665 |
|